651 related articles for article (PubMed ID: 29497422)
1. Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation
Stegemann-Koniszewski S; Behrens S; Boehme JD; Hochnadel I; Riese P; Guzmán CA; Kröger A; Schreiber J; Gunzer M; Bruder D
Front Immunol; 2018; 9():245. PubMed ID: 29497422
[TBL] [Abstract][Full Text] [Related]
2. TLR7 contributes to the rapid progression but not to the overall fatal outcome of secondary pneumococcal disease following influenza A virus infection.
Stegemann-Koniszewski S; Gereke M; Orrskog S; Lienenklaus S; Pasche B; Bader SR; Gruber AD; Akira S; Weiss S; Henriques-Normark B; Bruder D; Gunzer M
J Innate Immun; 2013; 5(1):84-96. PubMed ID: 23154432
[TBL] [Abstract][Full Text] [Related]
3. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
[TBL] [Abstract][Full Text] [Related]
4. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models.
Forbester JL; Clement M; Wellington D; Yeung A; Dimonte S; Marsden M; Chapman L; Coomber EL; Tolley C; Lees E; Hale C; Clare S; Udalova I; Dong T; Dougan G; Humphreys IR
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075938
[TBL] [Abstract][Full Text] [Related]
5. Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.
Kronstad LM; Seiler C; Vergara R; Holmes SP; Blish CA
J Immunol; 2018 Oct; 201(7):2117-2131. PubMed ID: 30143589
[TBL] [Abstract][Full Text] [Related]
6. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7.
Bourquin C; Schmidt L; Lanz AL; Storch B; Wurzenberger C; Anz D; Sandholzer N; Mocikat R; Berger M; Poeck H; Hartmann G; Hornung V; Endres S
J Immunol; 2009 Nov; 183(10):6078-86. PubMed ID: 19890064
[TBL] [Abstract][Full Text] [Related]
8. Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells.
Scharenberg M; Vangeti S; Kekäläinen E; Bergman P; Al-Ameri M; Johansson N; Sondén K; Falck-Jones S; Färnert A; Ljunggren HG; Michaëlsson J; Smed-Sörensen A; Marquardt N
Front Immunol; 2019; 10():1116. PubMed ID: 31156653
[TBL] [Abstract][Full Text] [Related]
9. Identification and Analysis of Natural Killer Cells in Murine Nasal Passages.
Okada K; Sato S; Sato A; Mandelboim O; Yamasoba T; Kiyono H
PLoS One; 2015; 10(11):e0142920. PubMed ID: 26575399
[TBL] [Abstract][Full Text] [Related]
10. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.
Draghi M; Pashine A; Sanjanwala B; Gendzekhadze K; Cantoni C; Cosman D; Moretta A; Valiante NM; Parham P
J Immunol; 2007 Mar; 178(5):2688-98. PubMed ID: 17312110
[TBL] [Abstract][Full Text] [Related]
11. Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I Proteins.
Rahim MMA; Parsons BD; Price EL; Slaine PD; Chilvers BL; Seaton GS; Wight A; Medina-Luna D; Dey S; Grandy SL; Anderson LE; Zamorano Cuervo N; Grandvaux N; Gaglia MM; Kelvin AA; Khaperskyy DA; McCormick C; Makrigiannis AP
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321802
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.
Abboud G; Tahiliani V; Desai P; Varkoly K; Driver J; Hutchinson TE; Salek-Ardakani S
J Virol; 2016 Jan; 90(1):129-41. PubMed ID: 26468539
[TBL] [Abstract][Full Text] [Related]
13. Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4.
Wong EB; Mallet JF; Duarte J; Matar C; Ritz BW
Nutr Res; 2014 Apr; 34(4):318-25. PubMed ID: 24774068
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
Sun R; Gao B
Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
[TBL] [Abstract][Full Text] [Related]
16. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
Dhariwala MO; Olson RM; Anderson DM
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
[No Abstract] [Full Text] [Related]
17. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
Vahlne G; Becker S; Brodin P; Johansson MH
Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
[TBL] [Abstract][Full Text] [Related]
18. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
[TBL] [Abstract][Full Text] [Related]
19. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
[TBL] [Abstract][Full Text] [Related]
20. Human TLR8 Senses RNA From
Coch C; Hommertgen B; Zillinger T; Daßler-Plenker J; Putschli B; Nastaly M; Kümmerer BM; Scheunemann JF; Schumak B; Specht S; Schlee M; Barchet W; Hoerauf A; Bartok E; Hartmann G
Front Immunol; 2019; 10():371. PubMed ID: 30972055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
